Skip to main content
. 2021 Sep 19;10(2):1567–1578. doi: 10.1007/s40122-021-00312-6

Table 1.

Baseline clinical characteristics and demographic data of the study participants

Parameter MPFF group (n = 42) Control group (n = 41) Total (N = 83)
Mean ± SD Range Mean ± SD Range Mean ± SD Range
Age (years) 34.7 ± 4.9 21–45 35.8 ± 5.9 19–55 34.4 ± 5.0 19–55
Body mass index (kg/m2) 22.3 ± 2.6 16.9–33.0 23.2 ± 3.1 17.4–32.5 22.7 ± 2.9 16.9–33.0
Age of disease onset (years) 29.3 ± 5.2 16–41 30.0 ± 6.5 16–46 29.8 ± 5.9 16–46
Duration of disease (years) 5.3 ± 3.7 0.5–20 6.0 ± 4.7 0.5–23 5.4 ± 4.1 0.5–23
Risk factors 1.7 ± 0.9 0–5 1.5 ± 0.8 0–4 1.6 ± 0.9 0–5
Age at menarche (years) 13.1 ± 1.0 9–17 13.4 ± 1.3 11–18 13.3 ± 1.2 9–18
Duration of menstrual cycle (days) 27.2 ± 1.4 24–31 26.9 ± 1.7 21–30 27.1 ± 1.5 21–31
Duration of menstrual bleeding (days) 4.9 ± 1.2 3–9 5.7 ± 1.2 2–11 5.2 ± 1.2 2–11
Number of pregnancies 2.5 ± 1.2 0–5 2.9 ± 1.3 0–7 2.6 ± 1.3 0–7
Number of births 1.7 ± 0.8 0–5 1.7 ± 0.8 0–4 1.7 ± 0.8 0–5
Number of miscarriages 0.1 ± 0.2 0–1 0.3 ± 0.5 0–2 0.2 ± 0.3 0–2
Number of medical abortions 0.6 ± 0.8 0–3 1.0 ± 1.0 0–5 0.8 ± 0.9 0–5